CannaPharmaRX

(OTC) CPMD

Current Price$0.00

Market Cap$2.37M

Since IPO (1999)-100%

5 Year-98%

1 Year+0%

1 Month-19%

CannaPharmaRX Financials at a Glance

Market Cap

$2.37M

Revenue (TTM)

$1.36M

Net Income (TTM)

$11.13M

EPS (TTM)

$-0.02

P/E Ratio

-0.21

Dividend

$0.00

Beta (Volatility)

-924.61 (Low)

Dividend

$0.00

Beta (Volatility)

-924.61 (Low)

Price

$0.00

Volume

2,000

Open

$0.00

Price

$0.00

Volume

2,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Dividend

$0.00

Beta (Volatility)

-924.61 (Low)

Price

$0.00

Volume

2,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

CPMD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About CannaPharmaRX

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Constantine Nkafu

Website

www.cannapharmarx.com

Headquarters

Calgary, AB T2P 5C5, CA

CPMD Financials

Key Financial Metrics (TTM)

Gross Margin

-2%

Operating Margin

-2%

Net Income Margin

-8%

Return on Equity

Return on Capital

14%

Return on Assets

-2%

Earnings Yield

-4.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.37M

Shares Outstanding

678.50M

Volume

2.00K

Avg. Volume

204.97K

Financials (TTM)

Gross Profit

$2.08M

Operating Income

$3.35M

EBITDA

$8.68M

Operating Cash Flow

$789.10K

Capital Expenditure

$5.52K

Free Cash Flow

$794.62K

Cash & ST Invst.

$1.80K

Total Debt

$20.65M

CannaPharmaRX Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$138.63K

-71.2%

Gross Profit

$521.09K

+69.2%

Gross Margin

-3.76%

N/A

Market Cap

$2.37M

N/A

Market Cap/Employee

$91.34K

N/A

Employees

N/A

Net Income

$7.55M

-101.8%

EBITDA

$6.94M

-366.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$20.65M

-46.9%

Accounts Receivable

$164.43K

+703.9%

Inventory

$1.12M

+12.0%

Long Term Debt

$5.58M

+14.1%

Short Term Debt

$15.07M

+64.4%

Return on Assets

-1.59%

N/A

Return on Invested Capital

13.59%

N/A

Free Cash Flow

$1.06M

+687.0%

Operating Cash Flow

$1.06M

+690.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EXMTAnything Technologies Media, Inc.

EXMTAnything Technologies Media, Inc.$0.00+0.00%

MSTHMystic Holdings, Inc.

MSTHMystic Holdings, Inc.$0.01+0.00%

CNNACann American Corp.

CNNACann American Corp.$0.00+0.00%

CBDYTarget Group Inc.

CBDYTarget Group Inc.$0.00-27.78%

PLSHPanacea Life Sciences Holdings, Inc.

PLSHPanacea Life Sciences Holdings, Inc.$0.03+0.00%

LVVEFYooma Wellness Inc.

LVVEFYooma Wellness Inc.$0.00+0.00%

MJARFMJardin Group, Inc.

MJARFMJardin Group, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

TSLATesla

TSLATesla$390.82+0.02%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About CPMD

What is the current price of CannaPharmaRX?

CannaPharmaRX is trading at $0.00 per share.

What is the 52-week range for CannaPharmaRX?

Over the past 52 weeks, CannaPharmaRX has traded between $0.00 and $0.01.

How much debt does CannaPharmaRX have?

As of the most recent reporting period, CannaPharmaRX reported total debt of $20.65M.

How much cash does CannaPharmaRX have on hand?

CannaPharmaRX reported $1,804 in cash and cash equivalents in its most recent financial results.

What is CannaPharmaRX’s dividend yield?

CannaPharmaRX does not currently have a dividend yield.

CannaPharmaRX

CannaPharmaRX Financials at a Glance

CPMD News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About CannaPharmaRX

CPMD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

CannaPharmaRX Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CPMD

What is the current price of CannaPharmaRX?

What is the 52-week range for CannaPharmaRX?

How much debt does CannaPharmaRX have?

How much cash does CannaPharmaRX have on hand?

What is CannaPharmaRX’s dividend yield?

Premium Investing Services